Greatwall promotes cell transformation by hyperactivating AKT in human malignancies

eLife

Volumn 4, Issue NOVEMBER2015, 2015, Pages

  Vera, Jorge ^a   Lartigue, Lydia ^b   Vigneron, Suzanne ^a   Gadea, Gilles ^a   Gire, Veronique ^a   Del Rio, Maguy ^c   Soubeyran, Isabelle ^b   Chibon, Frederic ^b   Lorca, Thierry ^a   Castro, Anna ^a  

^a Centre National de la Recherche Scientifique   (France)

^b INSERM   (France)

^c INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLYCOGEN SYNTHASE KINASE 3BETA; GREATWALL KINASE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; ONCOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; ENDOSULFINE; GLYCOGEN SYNTHASE KINASE 3; MASTL PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; NUCLEAR PROTEIN; PEPTIDE; PHLPP1 PROTEIN, HUMAN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SERINE THREONINE KINASE; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; BREAST CELL; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR INVASION; CELL LINE; METABOLISM; PHOSPHORYLATION; PROTEIN DEGRADATION; PROTEIN PROCESSING;

CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; SKP CULLIN F-BOX PROTEIN LIGASES;

EID: 84955255264     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.10115     Document Type: Article

References (37)

1. Adams DG, Coffee RL, Zhang H, Pelech S, Strack S, Wadzinski BE. 2005. Positive regulation of Raf1-MEK1/2- ERK1/2 signaling by protein Serine/Threonine phosphatase 2A holoenzymes. Journal of Biological Chemistry 280:42644-42654. doi: 10.1074/jbc.M502464200
2. Alvarez-Fernandez M, Sanchez-Martinez R, Sanz-Castillo B, Gan PP, Sanz-Flores M, Trakala M, Ruiz-Torres M, Lorca T, Castro A, Malumbres M. 2013. Greatwall is essential to prevent mitotic collapse after nuclear envelope breakdown in mammals. Proceedings of the National Academy of Sciences of the United States of America 110:17374-17379. doi: 10.1073/pnas.1310745110
3. Andrabi S, Gjoerup OV, Kean JA, Roberts TM, Schaffhausen B. 2007. Protein phosphatase 2A regulates life and death decisions via akt in a context-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 104:19011-19016. doi: 10.1073/pnas.0706696104
4. Baus F. 2003. Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. The EMBO Journal 22:3992-4002. doi: 10.1093/emboj/cdg387
5. Bettencourt-Dias M, Giet R, Sinka R, Mazumdar A, Lock WG, Balloux F, Zafiropoulos PJ, Yamaguchi S, Winter S, Carthew RW, Cooper M, Jones D, Frenz L, Glover DM. 2004. Genome-wide survey of protein kinases required for cell cycle progression. Nature 432:980-987. doi: 10.1038/nature03160
6. Blake-Hodek KA, Williams BC, Zhao Y, Castilho PV, Chen W, Mao Y, Yamamoto TM, Goldberg ML. 2012. Determinants for activation of the atypical AGC kinase greatwall during m phase entry. Molecular and Cellular Biology 32:1337-1353. doi: 10.1128/MCB.06525-11
7. Brognard J, Sierecki E, Gao T, Newton AC. 2007. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of akt signaling by regulating distinct akt isoforms. Molecular Cell 25:917-931. doi: 10.1016/j. molcel.2007.02.017
8. Burgess A, Vigneron S, Brioudes E, LabbéJ-C, Lorca T, Castro A. 2010. Loss of human greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin b-Cdc2/PP2A balance. Proceedings of the National Academy of Sciences of the United States of America 107:12564-12569. doi: 10.1073/pnas. 0914191107
9. Castilho PV, Williams BC, Mochida S, Zhao Y, Goldberg ML. 2009. The m phase kinase greatwall (gwl) promotes inactivation of PP2A/B55 , a phosphatase directed against CDK phosphosites. Molecular Biology of the Cell 20: 4777-4789. doi: 10.1091/mbc.E09-07-0643
10. Cheng Y, Liu W, Kim S-T, Sun J, Lu L, Sun J, Zheng SL, Isaacs WB, Xu J. 2011. Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study. Cancer Genetics 204:375-381. doi: 10.1016/j.cancergen.2011.05.002
11. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Caldas C, Aparicio S, Curtis† C, Shah SP, Caldas C, Aparicio S, Brenton JD, Ellis I, Huntsman D, Pinder S, Purushotham A, Murphy L, Caldas C, Aparicio S, Caldas C, Bardwell H, Chin S-F, Curtis C, Ding Z, Gräf S, Jones L, Liu B, Lynch AG, Papatheodorou I, Sammut SJ, Wishart G, Aparicio S, Chia S, Gelmon K, Huntsman D, McKinney S, Speers C, Turashvili G, Watson P, Ellis I, Blamey R, Green A, Macmillan D, Rakha E, Purushotham A, Gillett C, Grigoriadis A, Pinder S, di Rinaldis E, Tutt A, Murphy L, Parisien M, Troup S, Caldas C, Chin S-F, Chan D, Fielding C, Maia A-T, McGuire S, Osborne M, Sayalero SM, Spiteri I, Hadfield J, Aparicio S, Turashvili G, Bell L, Chow K, Gale N, Huntsman D, Kovalik M, Ng Y, Prentice L, Caldas C, TavaréS, Curtis C, Dunning MJ, Gräf S, Lynch AG, Rueda OM, Russell R, Samarajiwa S, Speed D, Markowetz F, Yuan Y, Brenton JD, Aparicio S, Shah SP, Bashashati A, Ha G, Haffari G, McKinney S, Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale A-L, Brenton JD, TavaréS, Caldas C, Aparicio S. 2012. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486:346-352. doi: 10. 1038/nature10983
12. Dazard JE. 2000. Role rgulateur des protines p53 et Mdm2 au cours de la diffrenciation terminale kratinocytairetaire. PhD thesis, Universitéde Montpellier I.
13. Del Rio M, Molina F, Bascoul-Mollevi C, Copois V, Bibeau F, Chalbos P, Bareil C, Kramar A, Salvetat N, Fraslon C, Conseiller E, Granci V, Leblanc B, Pau B, Martineau P, Ychou M. 2007. Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. Journal of Clinical Oncology 25:773-780. doi: 10.1200/JCO.2006.07.4187
14. Del Rio M, Mollevi C, Vezzio-Vie N, Bibeau F, Ychou M, Martineau P, Guan X-Y. 2013. Specific extracellular matrix remodeling signature of colon hepatic metastases. PLoS One 8:e74599. doi: 10.1371/journal.pone. 0074599
15. Eichhorn PJA, Creyghton MP, Wilhelmsen K, van Dam H, Bernards R. 2007. A RNA interference screen identifies the protein phosphatase 2A subunit PR55g as a stress-sensitive inhibitor of c-SRC. PLoS Genetics 3:e218. doi: 10.1371/journal.pgen.0030218
16. Gao T, Furnari F, Newton AC. 2005. PHLPP: a phosphatase that directly dephosphorylates akt, promotes apoptosis, and suppresses tumor growth. Molecular Cell 18:13-24. doi: 10.1016/j.molcel.2005.03.008
17. Gharbi-Ayachi A, Labbe J-C, Burgess A, Vigneron S, Strub J-M, Brioudes E, Van-Dorsselaer A, Castro A, Lorca T. 2010. The substrate of greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science 330:1673-1677. doi: 10.1126/science.1197048
18. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464-468. doi: 10.1038/22780
19. Henriksen M, Miller B, Newmark J, Al-Kofahi Y, Holden E. 2011. Laser scanning cytometry and its applications: a pioneering technology in the field of quantitative imaging cytometry. Methods in Cellular Biology 102:159-205. doi: 10.1016/B978-0-12-374912-3.00007-9
20. Janssens V, Longin S, Goris J. 2008. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends in Biochemical Sciences 33:113-121. doi: 10.1016/j.tibs.2007.12.004
21. Jullien L, Mestre M, Roux P, Gire V. 2013. Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response. Nucleic Acids Research 41:900-911. doi: 10.1093/nar/gks1121
22. Kuo Y-C, Huang K-Y, Yang C-H, Yang Y-S, Lee W-Y, Chiang C-W. 2008. Regulation of phosphorylation of thr-308 of akt, cell proliferation, and survival by the B55 regulatory subunit targeting of the protein phosphatase 2A holoenzyme to akt. Journal of Biological Chemistry 283:1882-1892. doi: 10.1074/jbc.M709585200
23. Land H, Parada LF, Weinberg RA. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602. doi: 10.1038/304596a0
24. Li X, Liu J, Gao T. 2009. -TrCP-mediated ubiquitination and degradation of PHLPP1 are negatively regulated by akt. Molecular and Cellular Biology 29:6192-6205. doi: 10.1128/MCB.00681-09
25. Lowe SW, Cepero E, Evan G. 2004. Intrinsic tumour suppression. Nature 432:307-315. doi: 10.1038/nature03098
26. Mochida S, Maslen SL, Skehel M, Hunt T. 2010. Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science 330:1670-1673. doi: 10.1126/science.1195689
27. Ory S, Zhou M, Conrads TP, Veenstra TD, Morrison DK. 2003. Protein phosphatase 2A positively regulates ras signaling by dephosphorylating KSR1 and raf-1 on critical 14-3-3 binding sites. Current Biology 13:1356-1364. doi: 10.1016/S0960-9822(03)00535-9
28. Pozarowski P, Holden E, Darzynkiewicz Z. 2013. Laser scanning cytometry: principles and applications-an update. Methods in Molecular Biology 931:187-212. doi: 10.1007/978-1-62703-056-4_11
29. Rodriguez-Viciana P, Collins C, Fried M. 2006. Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. Proceedings of the National Academy of Sciences of the United States of America 103:19290-19295. doi: 10.1073/pnas.0609343103
30. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ. 2008. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135:510-523. doi: 10.1016/j.cell.2008.09.043
31. Soubeyran I, Mahouche I, Grigoletto A, Leste-Lasserre T, Drutel G, Rey C, Pedeboscq S, Blanchard F, Brouste V, Sabourin J-C, Bécouarn Y, Reiffers J, Ichas F, De Giorgi F. 2011. Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function. The American Journal of Pathology 178:1986-1998. doi: 10.1016/j.ajpath.2011.01.021
32. Tan J, Lee PL, Li Z, Jiang X, Lim YC, Hooi SC, Yu Q. 2010. B55b-associated PP2A complex controls PDK1- directed myc signaling and modulates rapamycin sensitivity in colorectal cancer. Cancer Cell 18:459-471. doi: 10.1016/j.ccr.2010.10.021
33. Vigneron S, Brioudes E, Burgess A, LabbéJ-C, Lorca T, Castro A. 2009. Greatwall maintains mitosis through regulation of PP2A. The EMBO Journal 28:2786-2793. doi: 10.1038/emboj.2009.228
34. Vigneron S, Gharbi-Ayachi A, Raymond A-A, Burgess A, Labbe J-C, Labesse G, Monsarrat B, Lorca T, Castro A. 2011. Characterization of the mechanisms controlling greatwall activity. Molecular and Cellular Biology 31: 2262-2275. doi: 10.1128/MCB.00753-10
35. Virshup DM, Shenolikar S. 2009. From promiscuity to precision: protein phosphatases get a makeover. Molecular Cell 33:537-545. doi: 10.1016/j.molcel.2009.02.015
36. Yasutis K, Vignali M, Ryder M, Tameire F, Dighe SA, Fields S, Kozminski KG. 2010. Zds2p regulates Swe1p- dependent polarized cell growth in saccharomyces cerevisiae via a novel Cdc55p interaction domain. Molecular Biology of the Cell 21:4373-4386. doi: 10.1091/mbc.E10-04-0326
37. Yu J. 2004. Greatwall kinase: a nuclear protein required for proper chromosome condensation and mitotic progression in drosophila. The Journal of Cell Biology 164:487-492. doi: 10.1083/jcb.200310059